Innate Pharma (France) Price on November 28, 2024
IPH Stock | EUR 1.69 0.03 1.81% |
If you're considering investing in Innate Stock, it is important to understand the factors that can impact its price. As of today, the current price of Innate Pharma stands at 1.69, as last reported on the 11th of December 2024, with the highest price reaching 1.83 and the lowest price hitting 1.62 during the day. Innate Pharma holds Efficiency (Sharpe) Ratio of -0.0942, which attests that the entity had a -0.0942% return per unit of risk over the last 3 months. Innate Pharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Innate Pharma's Market Risk Adjusted Performance of 0.9354, risk adjusted performance of (0.07), and Standard Deviation of 3.19 to validate the risk estimate we provide.
Innate Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Innate |
Sharpe Ratio = -0.0942
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | IPH |
Estimated Market Risk
3.22 actual daily | 28 72% of assets are more volatile |
Expected Return
-0.3 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Innate Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Innate Pharma by adding Innate Pharma to a well-diversified portfolio.
Innate Pharma Valuation on November 28, 2024
It is possible to determine the worth of Innate Pharma on a given historical date. On November 28, 2024 Innate was worth 1.41 at the beginning of the trading date compared to the closed value of 1.44. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Innate Pharma stock. Still, in general, we apply an absolute valuation method to find Innate Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Innate Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Innate Pharma's related companies.
Open | High | Low | Close | Volume | |
1.42 | 1.43 | 1.40 | 1.42 | 50,222 | |
11/28/2024 | 1.41 | 1.44 | 1.41 | 1.44 | 23,205 |
1.42 | 1.44 | 1.41 | 1.42 | 39,859 |
Backtest Innate Pharma | | | Innate Pharma History | | | Innate Pharma Valuation | Previous | Next |
Innate Pharma Trading Date Momentum on November 28, 2024
On November 29 2024 Innate Pharma was traded for 1.42 at the closing time. The maximum traded price for the trading interval was 1.44 and the lowest daily price was 1.41 . The daily volume was recorded at 39.9 K. The volume of trading on 29th of November 2024 played a part in the next trading day price drop. The trading delta at closing time to the next closing price was 1.39% . The trading delta at closing time to the closing price today is 6.25% . |
Innate Pharma Fundamentals Correlations and Trends
By evaluating Innate Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Innate Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Innate financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Innate Pharma Stock history
Innate Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Innate is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Innate Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Innate Pharma stock prices may prove useful in developing a viable investing in Innate Pharma
Innate Pharma S.A., a clinical-stage biotechnology company, discovers and develops therapeutic antibodies for the treatment of cancer in France and internationally. The company was founded in 1999 and is based in Marseille, France. INNATE PHARMA operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 191 people.
Innate Pharma Stock Technical Analysis
Innate Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Innate Pharma Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Innate Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on Euronext Paris. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Innate Pharma December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Innate Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Innate Pharma shares will generate the highest return on investment. By undertsting and applying Innate Pharma stock market strength indicators, traders can identify Innate Pharma entry and exit signals to maximize returns
Innate Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Innate Pharma's price direction in advance. Along with the technical and fundamental analysis of Innate Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Innate to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.07) | |||
Jensen Alpha | (0.30) | |||
Total Risk Alpha | (0.84) | |||
Treynor Ratio | 0.9254 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Innate Stock analysis
When running Innate Pharma's price analysis, check to measure Innate Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innate Pharma is operating at the current time. Most of Innate Pharma's value examination focuses on studying past and present price action to predict the probability of Innate Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innate Pharma's price. Additionally, you may evaluate how the addition of Innate Pharma to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |